Executive snapshot
Structural heart markets are clinically compelling but complex. Adoption depends on multidisciplinary heart-team dynamics, procedural learning curves, patient selection, reimbursement, trial quality, and long-term outcomes.
Clinical workflow
Workflow analysis should include referral pathways, imaging workup, heart-team decision-making, procedure planning, device deployment, post-procedure management, and longitudinal follow-up.
Market dynamics
Key dynamics include procedure volume, patient eligibility, competition against surgery or medical management, device training, center-of-excellence concentration, reimbursement, and guideline evolution.
Evidence watch
Important endpoints may include mortality, hospitalization, functional status, hemodynamics, device durability, stroke, bleeding, vascular complications, reintervention, quality of life, and cost-effectiveness.
Competitive landscape
The landscape should be segmented by anatomical target, procedure type, device generation, patient population, procedural complexity, and whether the technology expands or competes within existing procedure categories.
KOL / stakeholder map
Stakeholders include interventional cardiologists, cardiac surgeons, imaging cardiologists, heart failure specialists, anesthesiologists, structural coordinators, trial investigators, and major society faculty.
MedTex perspective
The diligence question is not only whether a device can produce positive clinical data, but whether the target population, procedural pathway, operator base, and reimbursement environment can support durable adoption.